Source: wikibot/ldn-1641
= LDN 1641
{wiki=LDN_1641}
LDN 1641 is a compound that has been studied for its potential therapeutic effects, particularly in the context of neurodegenerative diseases and other conditions. It is a selective inhibitor of the enzyme glycogen synthase kinase 3 (GSK-3), which plays a critical role in various cellular processes, including cell survival, proliferation, and metabolism.